NCT04447833View on ClinicalTrials.gov

Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

June 17, 2020

Primary Completion Date

January 30, 2021

Study Completion Date

March 30, 2026

Conditions
ARDS, HumanCOVID
Interventions
DRUG

Mesenchymal Stromal Stem Cells - KI-MSC-PL-205

Allogeneic bone marrow derived mesenchymal stromal stem cells (MSCs).

Trial Locations (1)

75185

Uppsala University Hospital, Uppsala

All Listed Sponsors
collaborator

Uppsala University Hospital

OTHER

lead

Uppsala University

OTHER